Parties including pharma companies, banks and financial investors have until 19 March to table bids for Indian generic antibiotics specialist Orchid Pharma after a previous buyout deal tabled by Ingen Capital Group under bankruptcy proceedings was annulled.
India’s Orchid Pharma Is Back On The Market
An acrimonious end to a takeover bid for bankrupt Indian player Orchid Pharma has reopened the pathway for previously interested parties to table fresh bids.
